USPTO serial 79390974
ARC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 6, 2026
- Examiner
- HACK, ANDREA R
- Law office
- GENERIC WEB UPDATE
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ARC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amy L. Wright
Amy L. Wright Taft Stettinius & Hollister LLPOne Indiana SquareSuite 3500INDIANAPOLIS, IN 46204Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computers, computer hardware and computer peripheral devices; computer software, computer application software, application software for mobile devices, all of the aforesaid being downloadable or recorded and for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; Computer software, computer application software, application software for mobile devices, all of the aforesaid being downloadable or recorded and for the purpose of delivering training and educational content in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable and recorded computer software for generating reports concerning regulatory requirements in the medical and life sciences industries; downloadable and recorded computer software for delivering training in relation to regulatory requirements in the medical and life sciences industries; downloadable publications, namely, magazines, newsletters, periodicals and brochures, all in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable and recorded media including written, image, video, audio and visual content, and infographics, namely e-books, CDs, DVDs, audio and video recordings, digital image files, podcasts and webinars in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; downloadable toolkits containing education, teaching and training resources comprised of downloadable guidelines, reports and data relating to regulatory compliance in the medical and life sciences industries; downloadable guidelines, reports and data relating to regulatory compliance in the medical and life sciences industries; none of the aforesaid relating to betting or gambling services; none of the aforesaid relating to AI technology specifically used in relation to player protection technology or risk reduction technology in the betting and gambling sector; none of the aforesaid in relation to the manufacture, provision, or supply of microprocessors, motherboard chipsets, network interface controllers and integrated circuits, flash memory, graphics chips, embedded processors nor other devices or software related to electronic design automation solutions and services | ACTIVE | — |
| 035 | Business organization and administration, none of the foregoing in connection with the travel industry; providing office functions, none of the foregoing in connection with the travel industry; collection, compilation, analysis, reporting and dissemination of statistics, data and information, none of the foregoing in connection with the travel industry; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for regulatory approval of medical devices, medical technologies, medications, pharmaceuticals, and biotechnology; providing information online regarding preparing and filing applications for regulatory submission management; business and advisory consultancy services relating to obtaining and maintaining commercial product certifications | ACTIVE | — |
| 041 | Education services, namely, providing training courses, online and live classes, seminars, webinars, workshops and tutorials in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; providing of training in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; education services in the medical and life sciences industries; educational services in relation to regulatory compliance, issues, updates and developments; educational services in relation to data integrity, unique device identification and regulatory readiness; education and training in relation to compliance and legal aspects of the European union In vitro Diagnostic Regulation; education services relating to quality services in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; legal education services; publication of instructional literature, none of the foregoing in connection with the travel industry; publishing, reporting, and writing of texts, other than publicity texts, none of the foregoing in connection with the travel industry; arranging and conducting conferences, workshops, seminars, symposium, competitions, conventions and meetings in the medical and life sciences industries; writing, reporting and publication of non-downloadable guidelines, reports, data and case studies relating to the medical and life sciences industries; advisory and consultancy services relating to all abovementioned services; none of the aforesaid relating to betting or gambling services; none of the aforesaid relating to AI technology specifically used in relation to player protection technology or risk reduction technology in the betting and gambling sector. | ACTIVE | — |
| 042 | Scientific, technological and industrial analysis, research and design services in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; conducting and designing clinical trials for others; laboratory testing of materials; consultancy services related to laboratory testing of materials; clinical research in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and legal industries; biological research and medical research; site monitoring services; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical product evaluation; product quality evaluation; quality control services for others; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the medical and life sciences industries; scientific research, analysis, testing, and related scientific studies in the medical and life sciences industries; consulting services in the medical and life sciences industries; biotechnology, biotechnology research consulting services; pharmaceutical research and product development for use in manufacturing; consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; technical writing; technical writing for others; testing, analysis and evaluation of the services of others for the purpose of certification; testing of apparatus in the field of medical devices for certification purposes; electronic data storage; software as a service [SaaS] for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; software as a service [SaaS] for the purpose of delivering training, educational content and reports in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; providing online, non-downloadable software for the purpose of accessing, navigating, analysing, updating and identifying regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; providing online, non-downloadable software for the purpose of delivering training, educational content and reports in respect of regulatory and legislative requirements in the field of medicine, life sciences, pharmaceuticals, laboratory research, laboratory testing and law; software design, development and engineering, none of the foregoing in connection with the travel industry; computer software consultancy, none of the foregoing in connection with the travel industry; providing online, nondownloadable software for generating reports concerning regulatory requirements in the medical and life sciences industries; providing online, non-downloadable software for delivering training in relation to regulatory requirements in the medical and life sciences industries; information, consultancy and advisory services relating to all abovementioned services; none of the aforesaid relating to betting or gambling services; none of the aforesaid relating to AI technology specifically used in relation to player protection technology or risk reduction technology in the betting and gambling sector; none of the foresaid in relation to the manufacture, provision, or supply of microprocessors, motherboard chipsets, network interface controllers and integrated circuits, flash memory, graphics chips, embedded processors nor other devices or software related to electronic design automation solutions and services. | ACTIVE | — |
| 044 | Clinical medical consultation services; medical information; professional consultancy relating to health care; advisory services relating to medical and surgical instruments and devices; consulting and advisory services relating to obtaining and maintaining commerical product certifications for medical and surgical instruments and devices; consultancy and information services relating to medical, pharmaceutical and biopharmaceutical products; consulting and advisory services relating to the European Union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to the European Union medical device regulation (MDR); consulting and advisory services relating to medical aspects of the European Union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to medical aspects of the European Union medical device regulation (MDR); preparation of reports relating to medical matters; preparation of clinical and performance evaluation reports; preparation of clinical and performance evaluation reports for medical devices; information, consultancy and advisory services relating to all above mentioned services. | ACTIVE | — |
| 045 | Legal services; regulatory and legal compliance auditing; advisory services relating to regulatory affairs; expert consultancy relating to legal issues regulatory compliance consulting services in the life sciences fields; regulatory compliance consulting services in the life sciences fields namely, reviewing standards and practices to assist others with compliance with governmental laws, regulations and rules pertaining to medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; consulting and advisory services relating to legal aspects of the European Union in vitro diagnostic regulation (IVDR); consulting and advisory services relating to legal aspects of the European Union medical device regulation (MDR); legal support services; information, consultancy and advisory services relating to all above mentioned services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ARC Regulatory Limited
- Other trademarks owned by ARC Regulatory Limited
- Other trademarks owned by ARC Regulatory Limited
- Other trademarks owned by ARC Regulatory Limited
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named ARC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 14, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 14, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 6, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 6, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 6, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2025 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Dec 14, 2025 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Dec 11, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Aug 26, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 22, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 6, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 6, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 5, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 5, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 30, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 1, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2024 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Nov 29, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Nov 15, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 15, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 15, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 15, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 29, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 29, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 29, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 23, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 14, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 23, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 23, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 11, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 10, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 10, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Apr 24, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 19, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 17, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 12, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 10, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 7, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |